IMMUNE-ONC THERAPEUTICS
Immune-Onc Therapeutics is a newly established bio-pharmaceutical company that focuses on developing innovative therapeutic antibodies for cancer treatment. The company applies the latest scientific insights and expertise in drug development to advance novel immuno-oncology products and bring new treatment options to cancer patients.
IMMUNE-ONC THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Health Care Medical Therapeutics
Founded:
2016-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.immune-onc.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
115.14 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Content Delivery Network Organization Schema Cloudflare JS CDN JS GoDaddy DNS Typekit
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Intellia Therapeutics
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Employees Featured
Founder
Investors List
Sphera Global Healthcare Fund
Sphera Global Healthcare Fund investment in Series B - Immune-Onc Therapeutics
Oceanpine Capital
Oceanpine Capital investment in Series B - Immune-Onc Therapeutics
Northern Light Venture Capital
Northern Light Venture Capital investment in Series B - Immune-Onc Therapeutics
Vivo Capital
Vivo Capital investment in Series B - Immune-Onc Therapeutics
Octagon Capital Advisors
Octagon Capital Advisors investment in Series B - Immune-Onc Therapeutics
Leukemia & Lymphoma Society
Leukemia & Lymphoma Society investment in Series B - Immune-Onc Therapeutics
National Cancer Institute
National Cancer Institute investment in Grant - Immune-Onc Therapeutics
Vivo Capital
Vivo Capital investment in Series B - Immune-Onc Therapeutics
StartX (Stanford-StartX Fund)
StartX (Stanford-StartX Fund) investment in Series B - Immune-Onc Therapeutics
Northern Light Venture Capital
Northern Light Venture Capital investment in Series B - Immune-Onc Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-14 | Immune-Onc Therapeutics Announces Appointment of Christopher Whitmore as Chief Financial Officer and Provides Clinical Progress Update |
Official Site Inspections
http://www.immune-onc.com Semrush global rank: 4.49 M Semrush visits lastest month: 2.39 K
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
